HealthTell, Inc.
HealthTell is a biotechnology company that has developed an unprecedented platform for the early detection and classification of disease from just a simple drop of blood.
Over ten years of scientific effort has demonstrated the power of the HealthTell ImmunoSignature technology across over 30 diseases. Our goal is to provide the medical industry with a tool that will change the face of diagnostics; a simple, affordable, accurate diagnostic test.
Over 170 million people, in the US alone, are affected by neurological, autoimmune, oncologic, metabolic and infectious diseases. These diseases create significant economic burdens totaling over a trillion dollars. HealthTell will enable early detection of diseases, when behavioral and therapeutic interventions are most effective. This will result in saving millions of lives, while reducing healthcare economics.
HealthTell’s mission is to provide the most accurate and affordable diagnostic for early disease detection—all from a simple drop of blood.
Please visit our Privacy Policy at:
http://www.healthtell.com/privacy-policy/
ImmunoSignature Disease Diagnostic Test
